Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials With Time‐to‐Event Outcomes

Oncologist - United States
doi 10.1634/theoncologist.2019-0464
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

The Use of Propensity Score Methods With Survival or Time-To-Event Outcomes: Reporting Measures of Effect Similar to Those Used in Randomized Experiments

Statistics in Medicine
EpidemiologyStatisticsProbability
2013English

Adjustment for Treatment Changes in Epilepsy Trials: A Comparison of Causal Methods for Time-To-Event Outcomes

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2017English

Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials

Nutrients
NutritionFood ScienceDietetics
2019English

Three Phase III Randomized Controlled Trials of Topical Resiquimod 0.01-Percent Gel to Reduce Anogenital Herpes Recurrences

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Covariate Adjustment in Randomized Trials With Binary Outcomes: Targeted Maximum Likelihood Estimation

Statistics in Medicine
EpidemiologyStatisticsProbability
2009English

Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail the Last Barrier?

International Journal of Cancer
Cancer ResearchOncology
2018English

Randomized Controlled Trials

Phlebology
MedicineCardiovascular MedicineCardiology
2011English

Empirical Comparison of Four Baseline Covariate Adjustment Methods in Analysis of Continuous Outcomes in Randomized Controlled Trials

Clinical Epidemiology
Epidemiology
2014English

Undisclosed Changes in Outcomes in Randomized Controlled Trials: An Observational Study

Annals of Family Medicine
Family Practice
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy